ASX:AVH

AVITA Medical (AVH) Stock Price, News & Analysis

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
27.28 million shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
0.30%
Price Target
N/A
AVH stock logo

About AVITA Medical Stock (ASX:AVH)

AVITA Medical, Inc., together with its subsidiaries, operates as a regenerative medicine company in the United States and internationally. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds, full-thickness skin defects, and repigmentation of stable depigmented vitiligo lesions. It develops RECELL GO to control the manual process of disaggregation, filtration, and soak time. The company was formerly known as AVITA Therapeutics, Inc. AVITA Medical, Inc. was incorporated in 2020 and is headquartered in Valencia, California.

AVH Stock News Headlines

The Gold Grab of the Century
When central banks buy gold… The rich buy right along with them. And central banks are buying at breakneck pace. Last year… 1,037 tons. Just 45 tons less than the record set two years ago.
RCEL Jul 2024 20.000 put
RCEL Jul 2024 12.500 put
AVITA Medical: Q4 Earnings Insights
The Gold Grab of the Century
When central banks buy gold… The rich buy right along with them. And central banks are buying at breakneck pace. Last year… 1,037 tons. Just 45 tons less than the record set two years ago.
Earnings Preview: AVITA Medical
What 4 Analyst Ratings Have To Say About AVITA Medical
AVITA Medical Updates Full Year 2023 Guidance
AVITA Medical Shares Up 13% As Revenue Surges In Q3
Avita Medical Shares Rise After Strong 3Q
See More Headlines
Receive AVH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for AVITA Medical and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/28/2019
Today
4/26/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Medical Devices
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
207
Year Founded
N/A

Profitability

Net Income
$-35,380,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$50.14 million
Book Value
A$1.91 per share

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
1.29
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Key Executives

  • Mr. James M. Corbett (Age 66)
    CEO, President & Executive Director
    Comp: $1.77M
  • Mr. David O'Toole (Age 65)
    Chief Financial Officer
    Comp: $878.88k
  • Ms. Donna Shiroma (Age 61)
    General Counsel, Chief Compliance Officer & Secretary
    Comp: $1.05M
  • Mr. David Fencil
    Senior Vice President of Global Operations
  • Dr. Katie Bush Ph.D.
    Senior Vice President of Scientific & Medical Affairs
  • Ms. Jessica Ekeberg
    Investor Relations Executive
  • Ms. Debbie Garner
    Senior Vice President of Global Marketing & Strategy
  • Mr. Rob Hall
    Senior Vice President of Human Resources
  • Mr. Terry Bromley
    Senior Vice President of Global Sales
  • Dr. Niraj Doshi J.D.
    P.M.P., Ph.D., Senior Vice President of Product Development & Program Management

AVH Stock Analysis - Frequently Asked Questions

How were AVITA Medical's earnings last quarter?

AVITA Medical, Inc. (ASX:AVH) released its earnings results on Thursday, February, 28th. The company reported ($0.02) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.01) by $0.01. AVITA Medical had a negative trailing twelve-month return on equity of 52.89% and a negative net margin of 70.56%.

What other stocks do shareholders of AVITA Medical own?
This page (ASX:AVH) was last updated on 4/26/2024 by MarketBeat.com Staff

From Our Partners